Unveiling a novel AAK1 inhibitor: How chemical proteomics unlock therapeutic potential

Enhancing drug development for life-threatening diseases like cancer hinges on a deep understanding of protein kinases, making it a focal point for researchers. These enzymes, encoded by more than 500 human genes, serve as critical players in cellular signaling pathways.